Literature DB >> 16391416

Altered expression of adenosine receptors in heart of diabetic rat.

M Grdeń1, M Podgórska, A Szutowicz, T Pawełczyk.   

Abstract

Diabetes results in functional, biochemical, and morphological abnormalities in the heart. Some of these changes may be attributed to altered adenosine action. This study aimed to examine the expression level of adenosine receptors (AR) in heart of streptozotocin-induced diabetic rat. Performed analyses revealed detectable levels of A1-AR, A2a-AR, A2b-AR, A3-AR mRNA and protein in whole heart and isolated cardiac myocytes. An increase in A1-AR protein content with no changes in mRNA level was observed in isolated cardiac myocytes. Diabetes resulted in an increase of A3-AR mRNA and protein levels in heart and in cardiac myocytes. The level of A2a-AR mRNA was increased in whole diabetic heart, but it decreased in cardiac myocytes with no detectable changes in protein content. We did not observe any changes in expression level of A2b-AR in diabetic heart and isolated cardiac myocytes. Administration of insulin to diabetic rat for four days resulted in returning of the ARs mRNA and protein to the levels observed in heart of normal rat. These changes in ARs genes expression, and receptors protein content correspond to some abnormalities characteristic of the diabetic heart, suggesting involvement in pathogenesis of diabetic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16391416

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  19 in total

1.  Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury.

Authors:  Ming Cai; Zachary M Huttinger; Heng He; Weizhi Zhang; Feng Li; Lauren A Goodman; Debra G Wheeler; Lawrence J Druhan; Jay L Zweier; Karen M Dwyer; Guanglong He; Anthony J F d'Apice; Simon C Robson; Peter J Cowan; Richard J Gumina
Journal:  J Mol Cell Cardiol       Date:  2011-09-12       Impact factor: 5.000

2.  A(2b) adenosine receptors can change their spots.

Authors:  Michael V Cohen; Xiulan Yang; James M Downey
Journal:  Br J Pharmacol       Date:  2010-04       Impact factor: 8.739

Review 3.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

Review 4.  Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations.

Authors:  Luca Antonioli; Corrado Blandizzi; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Nat Rev Endocrinol       Date:  2015-02-17       Impact factor: 43.330

Review 5.  Targeting of adenosine receptors in ischemia-reperfusion injury.

Authors:  Victor E Laubach; Brent A French; Mark D Okusa
Journal:  Expert Opin Ther Targets       Date:  2010-11-29       Impact factor: 6.902

6.  Functional changes in vascular reactivity to adenosine receptor activation in type I diabetic mice.

Authors:  Hicham Labazi; Bunyen Teng; S Jamal Mustafa
Journal:  Eur J Pharmacol       Date:  2017-12-18       Impact factor: 4.432

7.  Cannabidiol arrests onset of autoimmune diabetes in NOD mice.

Authors:  Lola Weiss; Michael Zeira; Shoshana Reich; Shimon Slavin; Itamar Raz; Raphael Mechoulam; Ruth Gallily
Journal:  Neuropharmacology       Date:  2007-07-17       Impact factor: 5.250

8.  Enhanced A2A adenosine receptor-mediated increase in coronary flow in type I diabetic mice.

Authors:  Hicham Labazi; Bunyen Teng; Zhichao Zhou; S Jamal Mustafa
Journal:  J Mol Cell Cardiol       Date:  2015-12-02       Impact factor: 5.000

Review 9.  A2A receptors in inflammation and injury: lessons learned from transgenic animals.

Authors:  György Haskó; Pál Pacher
Journal:  J Leukoc Biol       Date:  2007-12-26       Impact factor: 4.962

10.  Adenosine receptors and second messenger signaling pathways in rat cardiac fibroblasts.

Authors:  Sara A Epperson; Laurence L Brunton; Israel Ramirez-Sanchez; Francisco Villarreal
Journal:  Am J Physiol Cell Physiol       Date:  2009-02-25       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.